Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

As a result, we have seen drugs for increasingly chronic orphan indications such as Gleevec in CML charging up to almost $100,000 per year per patient. However, this has proven to be a double ...

Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...